Trifluridine / tipiracil (FTd / TPI, TAS-102) in the treatment of patients with metastatic colon cancer: from preclinical experiments to routine clinical practice

Yazar: M. Yu. Fedyanin
Baskı/Yayın Bilgisi 2020-12-01

Practical recommendation for treatment of patients with colon cancer during covid-19 pandemic

Yazar: M. Yu. Fedyanin
Baskı/Yayın Bilgisi 2020-07-01

Aflibercept: side effects in focus

Yazar: M. Yu. Fedyanin
Baskı/Yayın Bilgisi 2018-07-01

Metronomic chemotherapy regimens in oncology

Yazar: M. Yu. Fedyanin, I. A. Pokataev, S. A. Tyulyandin
Baskı/Yayın Bilgisi 2016-04-01

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-02-01

Localization of the primary tumor of the colon: аre there essential differences?

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2017-12-01

Role of microsatellite instability in colon cancer

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-02-01

CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-05-01

Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer?

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tyulyandin
Baskı/Yayın Bilgisi 2015-10-01

FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-02-01

Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2018-07-01

PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-02-01

Chemotherapy of metastatic colon cancer

Yazar: M. Yu. Fedyanin, A. А. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-02-01

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY

Yazar: M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2015-02-01

The role of circulating tumor DNA in patients with colon cancer

Yazar: M. Yu. Fedyanin, E. M. Polyanskaya, S. A. Tjulyandin
Baskı/Yayın Bilgisi 2016-10-01

Heterogeneity and clonal evolution of colorectal cancer

Yazar: M. Yu. Fedyanin, H. H.-M. Elsnukaeva, S. A. Tjulandin
Baskı/Yayın Bilgisi 2017-04-01

Colorectal cancer, screening: achievements и opportunities

Yazar: E. A. Polyanskaya, M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Baskı/Yayın Bilgisi 2018-12-01

Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer

Yazar: M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. A. Tyulyandin
Baskı/Yayın Bilgisi 2017-04-01

Prospects of therapeutic action on FGFR signaling pathway

Yazar: M. Yu. Fedyanin, D. N. Khmelkova, T. S. Serebriyskaya, T. A. Nikolskaya, S. A. Tyulyandin
Baskı/Yayın Bilgisi 2015-06-01

Some aspects of immunotherapy in colon cancer

Yazar: M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, A. A. Tryakin, S. A. Tyulyandin
Baskı/Yayın Bilgisi 2018-05-01